Morphine Equivalent Dose (MED) remains a valuable indicator of risk when it comes to opioids, and we continue to see downward trends through 2018 that align with best practice recommendations. In particular, declines in long-term high MED opioid claims and an increase in the presence of opioid overdose reversal agents when MED is over 50 represent two areas that impact patient safety. Recognizing such indicators of risk can aid in identifying opportunities for intervention particularly through outreach with medical providers and/or injured workers, medication review, ongoing monitoring, and recommendations for guideline-supported risk-reducing measures. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Specialty Solutions Spotlight: Using Quality Physical Therapy First for Low Back Pain Helps Reduce Costs and Improves Outcomes
Should an MRI be the first step in addressing work-related lower back pain injuries?The U.S.
Workers' Comp
News Release
Enlyte Announces Its 2024 Heart of Case Management Award Winners
Honorees represent the best of those who make a profound impact on the lives of employees with injuries and disabilitiesS
WorkCompCentral
In the News
Enlyte Launches Physical Medicine Network
Business Insurance
In the News
Enlyte launches specialty service for injured workers
Workers' Comp
News Release
Enlyte Launches Apricus Physical Medicine, Offering End-to-End Specialty Service Solution for Industry
New program introduces comprehensive rehabilitative services with integrated clinical oversight and continuous care coordination
Auto Casualty
Article
Balanced Regulatory Environment: A Key Component to Unlocking the Value of Specialty Bill Review
Without the use of Specialty Bill Review (SBR), payers risk paying for errors or abuses created by providers with problematic billing practices.